Cargando…

RP105-Negative B Cells in Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a multisystem disease characterized by B cells producing autoantibodies against nuclear proteins and DNA, especially anti-double-strand DNA (dsDNA) antibodies. RP105 (CD180), the toll-like receptor- (TLR-) associated molecule, is expressed on normal B cells. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koarada, Syuichi, Tada, Yoshifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175410/ https://www.ncbi.nlm.nih.gov/pubmed/21941580 http://dx.doi.org/10.1155/2012/259186

Ejemplares similares

Phenotyping of P105-Negative B Cell Subsets in Patients with Systemic Lupus Erythematosus
por: Koarada, Syuichi, et al.
Publicado: (2012)

Increased RP105-Negative B Cells in IgG4-Related Disease
por: Koarada, S, et al.
Publicado: (2013)

Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis
por: Tada, Yoshifumi, et al.
Publicado: (2008)

Immediate Effect of Baricitinib on Arthritis and Biological Disease-Modifying Antirheumatic Drug-Induced Psoriasis-Like Skin Lesions in Two Patients with Rheumatoid Arthritis
por: Tada, Yoshifumi, et al.
Publicado: (2021)

B cell abnormalities in systemic lupus erythematosus
por: Grammer, Amrie C, et al.
Publicado: (2003)

The Molecular Mechanism of B Cell Activation by toll-like Receptor Protein RP-105
por: Chan, Vivien W.F., et al.
Publicado: (1998)

The Toll-like Receptor Protein Rp105 Regulates Lipopolysaccharide Signaling in B Cells
por: Ogata, Hirotaka, et al.
Publicado: (2000)

TLR Accessory Molecule RP105 (CD180) Is Involved in Post-Interventional Vascular Remodeling and Soluble RP105 Modulates Neointima Formation
por: Karper, Jacco C., et al.
Publicado: (2013)

Emerging B-Cell Therapies in Systemic Lupus Erythematosus
por: Bag-Ozbek, Ayse, et al.
Publicado: (2021)

Aberrant B-Cell Activation in Systemic Lupus Erythematosus
por: Kang, Na, et al.
Publicado: (2022)

The Role of B Cell and T Cell Glycosylation in Systemic Lupus Erythematosus
por: Ramos-Martínez, Ivan, et al.
Publicado: (2023)

CD72 is a Negative Regulator of B Cell Responses to Nuclear Lupus Self-antigens and Development of Systemic Lupus Erythematosus
por: Tsubata, Takeshi
Publicado: (2019)

Systemic lupus erythematosus
por: Manson, Jessica J, et al.
Publicado: (2006)

Multiple Functions of B Cells in the Pathogenesis of Systemic Lupus Erythematosus
por: Ma, Kongyang, et al.
Publicado: (2019)

Research Progress on Regulatory B Cells in Systemic Lupus Erythematosus
por: Wang, Tao, et al.
Publicado: (2019)

Systemic Lupus Erythematosus
por: Peng, Stanford
Publicado: (1993)

The Pathology of T Cells in Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2014)

Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis
por: Wang, Wenxia, et al.
Publicado: (2022)

B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab
por: Wiesik-Szewczyk, E, et al.
Publicado: (2012)

Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus
por: Ma, Kongyang, et al.
Publicado: (2015)

Complement and systemic lupus erythematosus
por: Walport, Mark J
Publicado: (2002)

Systemic lupus erythematosus and thrombosis
por: Bazzan, Mario, et al.
Publicado: (2015)

Systemic Lupus Erythematosus and Immunodeficiency
por: Chan, Shirley Chiu Wai, et al.
Publicado: (2021)

Abnormalities of T cell signaling in systemic lupus erythematosus
por: Moulton, Vaishali R, et al.
Publicado: (2011)

The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis
por: Tada, Yoshifumi, et al.
Publicado: (2016)

B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis—Role in Pathogenesis and Effect of Immunosuppressive Treatments
por: Yap, Desmond Y. H., et al.
Publicado: (2019)

Double negative T cells, a potential biomarker for systemic lupus erythematosus
por: Alexander, Jessy J, et al.
Publicado: (2020)

The lupus band test in systemic lupus erythematosus patients
por: Reich, Adam, et al.
Publicado: (2011)

The Role of γδ T Cells in Systemic Lupus Erythematosus
por: Wu, Meng, et al.
Publicado: (2016)

Immunoregulation of NKT Cells in Systemic Lupus Erythematosus
por: Chen, Junwei, et al.
Publicado: (2015)

Follicular Regulatory T Cells in Systemic Lupus Erythematosus
por: Xia, Xin, et al.
Publicado: (2021)

Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α Inhibitors
por: Koarada, Syuichi, et al.
Publicado: (2015)

Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond
por: Cooper, Elizabeth E., et al.
Publicado: (2021)

Analysis of B-cell subpopulations in systemic lupus erythematosus
por: Dorner, T, et al.
Publicado: (2003)

The Role of B1 Cells in Systemic Lupus Erythematosus
por: She, Zhou, et al.
Publicado: (2022)

Toll-like receptor signalling in B cells during systemic lupus erythematosus
por: Fillatreau, Simon, et al.
Publicado: (2020)

Cytokine disturbances in systemic lupus erythematosus
por: Jacob, Noam, et al.
Publicado: (2011)

Genetic epidemiology: Systemic lupus erythematosus
por: Ahmad, Yasmeen A, et al.
Publicado: (2001)

Epigenetic Aspects of Systemic Lupus Erythematosus
por: Relle, Manfred, et al.
Publicado: (2015)

Role of Osteopontin in Systemic Lupus Erythematosus
por: Kaleta, Beata
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5l3f8n42fo4g6asf82f9k9fu1a